These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 843984)

  • 61. Inhibition of neutrophil chemotaxis by soluble bacterial products.
    Van Dyke TE; Bartholomew E; Genco RJ; Slots J; Levine MJ
    J Periodontol; 1982 Aug; 53(8):502-8. PubMed ID: 6956714
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chemotactic peptide modulation of actin assembly and locomotion in neutrophils.
    Howard TH; Meyer WH
    J Cell Biol; 1984 Apr; 98(4):1265-71. PubMed ID: 6232281
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Localization of submembranous cations to the leading end of human neutrophils during chemotaxis.
    Cramer EB; Gallin JI
    J Cell Biol; 1979 Aug; 82(2):369-79. PubMed ID: 479306
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
    Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
    Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Analysis of neutrophil polarization and chemotaxis.
    Lokuta MA; Nuzzi PA; Huttenlocher A
    Methods Mol Biol; 2007; 412():211-29. PubMed ID: 18453114
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Angiopoietin chemotactic activities on neutrophils are regulated by PI-3K activation.
    Brkovic A; Pelletier M; Girard D; Sirois MG
    J Leukoc Biol; 2007 Apr; 81(4):1093-101. PubMed ID: 17215522
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Concentration optimization of combinatorial drugs using Markov chain-based models.
    Ma S; Dang D; Wang W; Wang Y; Liu L
    BMC Bioinformatics; 2021 Sep; 22(1):451. PubMed ID: 34548014
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sensitivity analysis of Markov models for communities of competing sessile organisms.
    Spencer M
    J Anim Ecol; 2006 Jul; 75(4):1024-33. PubMed ID: 17009765
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Building mean field ODE models using the generalized linear chain trick & Markov chain theory.
    Hurtado PJ; Richards C
    J Biol Dyn; 2021 May; 15(sup1):S248-S272. PubMed ID: 33847236
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Markov chain aggregation and its applications to combinatorial reaction networks.
    Ganguly A; Petrov T; Koeppl H
    J Math Biol; 2014 Sep; 69(3):767-97. PubMed ID: 24253253
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A general approach to non-Markovian compartmental models.
    Matis JH; Wehrly TE
    J Pharmacokinet Biopharm; 1998 Aug; 26(4):437-56. PubMed ID: 10214561
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Simulation of Mendelism by a non-genetic Markov chain model.
    Wilson SR
    Ann Hum Genet; 1974 Oct; 38(2):225-9. PubMed ID: 4467784
    [No Abstract]   [Full Text] [Related]  

  • 73. Statistical Analysis of Notational AFL Data Using Continuous Time Markov Chains.
    Meyer D; Forbes D; Clarke SR
    J Sports Sci Med; 2006; 5(4):525-32. PubMed ID: 24357946
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Low-rank tensor methods for Markov chains with applications to tumor progression models.
    Georg P; Grasedyck L; Klever M; Schill R; Spang R; Wettig T
    J Math Biol; 2022 Dec; 86(1):7. PubMed ID: 36460900
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Overshoot in biological systems modelled by Markov chains: a non-equilibrium dynamic phenomenon.
    Jia C; Qian M; Jiang D
    IET Syst Biol; 2014 Aug; 8(4):138-45. PubMed ID: 25075526
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Counting generations in birth and death processes with competing Erlang and exponential waiting times.
    Belluccini G; López-García M; Lythe G; Molina-París C
    Sci Rep; 2022 Jul; 12(1):11289. PubMed ID: 35789162
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Markov chain model and its application.
    Jain S
    Comput Biomed Res; 1986 Aug; 19(4):374-8. PubMed ID: 3731760
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A Markov transition model in the analysis of the immune response.
    McGilchrist CA; Aisbett CW; Cooper S
    J Theor Biol; 1989 May; 138(1):17-21. PubMed ID: 2626064
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Control Markov chain models for biological hierarchies.
    Nicolis JS; Protonotarios EN; Voulodemou I
    J Theor Biol; 1977 Oct; 68(4):563-81. PubMed ID: 926808
    [No Abstract]   [Full Text] [Related]  

  • 80. A Markov chain approximation of conjugal history.
    Krishnan P
    Sociol Rev Monogr; 1977 Jun; 24():127-33. PubMed ID: 918684
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.